Mannose-binding lectin and susceptibility to infection in Chinese patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 34, Issue 6, 2007, Pages 1270-1276

  Mok, Mo Yin ^a,b   Ip, W K Eddie ^a,c   Lau, Chak Sing ^a,d   Lo, Yi ^a,e   Wong, Wilfred H S ^a,b   Lau, Yu Lung ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Department of Medicine ^*  (United States)

^e Division of Rheumatology

Author keywords

Complement deficiency; Hospitalization; Immunocompromised host; Immunosuppressant; Infection

Indexed keywords

MANNOSE BINDING LECTIN; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHINESE; DISEASE EXACERBATION; FEMALE; GENE; GENETIC PREDISPOSITION; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; LECTIN BINDING; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MBL2 GENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; X CHROMOSOME; Y CHROMOSOME;

ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; CHINA; COHORT STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; MUTATION; OPPORTUNISTIC INFECTIONS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 34250206014     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Takahashi K, Ip WE, Michelow IC, Ezekowitz RA. The mannose-binding lectin: a prototypic pattern recognition molecule. Curr Opin Immunol 2006;18:16-23. Epub 2005 Dec 20.
2. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003;40:423-9.
3. Thiel S, Vorup-Jensen T, Stover CM, et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997;386:506-10.
4. Jack DL, Jarvis GA, Booth CL, Turner MW, Klein NJ. Mannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup C. J Infect Dis 2001;184:836-45.
5. Jack DL, Lee ME, Turner MW, Klein NJ, Read RC. Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages. J Leukoc Biol 2005;77:328-36.
6. Neth O, Jack DL, Johnson M, Klein NJ, Turner MW. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J Immunol 2002;169:4430-6.
7. Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson-Weller A. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med 2000;192:1797-808.
8. Ogden CA, de Cathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001;194:781-95.
9. Ip WK, Chan KH, Tso HK, et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005;191:1697-704.
10. Polotsky VY, Belisle JT, Mikusova K, Ezekowitz RA, Joiner KA. Interaction of human mannose-binding protein with mycobacterium avium. J Infect Dis 1997;175:1159-68.
11. Ip WK, Lau YL. Role of mannose-binding lectin in the innate defense against Candida albicans: enhancement of complement activation, but lack of opsonic function, in phagocytosis by human dendritic cells. J Infect Dis 2004;190:632-40.
12. White MR, Crouch E, Chang D, Harshorn KL. Increased anti-viral and opsonic activity of a highly multimeric collectin chimera. Biochem Biophys Res Commun 2001;286:206-13.
13. Haurum JS, Thiel S, Jones IM, Fisher PB, Laursen SB, Jensenius JC. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 1993;7:1307-13.
14. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 1989;25:1236-9.
15. Koch A, Melbye M, Sorensen P, et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 2001;10:1316-21.
16. Lau YL, Chan SY, Turner MW, Fong J, Karlberg J. Mannose-binding protein in preterm infants: developmental profile and clinical significance. Clin Exp Immunol 1995;102:649-54.
17. Summerfield JA, Ryder S, Sumiya M, et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995;345:886-9.
18. Kakkannaiah VN, Shen GQ, Ojo-Amaize EA, Peter JB. Association of low concentrations of serum mannose-binding protein with recurrent infections in adults. Clin Diagn Lab Immunol 1998;5:319-21.
19. Garred P, Madsen HO, Hofman B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding protein alleles in patients with suspected immunodeficiency. Lancet 1995;346:941-3.
20. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997;314:1229-32.
21. Jack DL, Turner MW. Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 2003;31:753-7.
22. Shi L, Takahashi K, Dundee J, et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 2004;10:1379-90.
23. Garred P, Madsen HO, Halberg P, et al. Mannose-binding lectin polymorphism and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 1999;42:2145-52.
24. Lau YL, Lau CS, Chan SY, Karlberg J, Turner MW. Mannose-binding protein in Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:706-8.
25. Takahashi R, Tsutsumi A, Ohtani K, et al. Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Ann Rheum Dis 2005,64:311-4.
26. Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. New Eng J Med 2004;351:260-7.
27. Madsen HO, Garred P, Kurtzhals JAL, Lamm LU, Ryder LP, Thiel S. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994;40:37-44.
28. Lipscombe RJ, Sumiya M, Hill AVS, et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein. Hum Mol Genet 1992;9:709-15.
29. Lipscombe RJ, Beatty DW, Ganczakowski M, et al. Mutation in the human mannose-binding protein gene: frequencies in several population groups. Eur J Hum Genet 1996;4:13-9.
30. Ip WK, Lau YL, Chan SY, et al. Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum 2000;43:1679-87.
31. Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013-20.
32. Ip WK, Chan SY, Lau CS, Lau YL. Association of systemic lupus erythematosus with promoter polymorphism of the mannose-binding lectin gene. Arthritis Rheum 1998;41:1663-8.
33. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
34. Ip WK, To YF, Cheng SK, Lau YL. Serum mannose-binding lectin levels and MBL2 gene polymorphisms in different age and gender groups of Southern Chinese adults. Scand J Immunol 2004;59:310-4.
35. Tso HW, Lau YL, Tarn CM, Wong HS, Chiang AK. Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population. J Infect Dis 2004;190:913-9.
36. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infection after chemotherapy. Lancet 2001;358:637-8.
37. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: A prospective study. Lancet 2001;358:637-8.
38. Summerfield JA. Clinical potential of mannose-binding lectin-replacement therapy. Biochem Soc Trans 2003;31:770-3.
39. Worthley DL, Bardy PG, Mullighan CG. Mannose-binding lectin: biology and clinical implications. Intern Med J 2005;35:548-55.
40. Jensenius JC, Jensen PH, Mcguire K, Larsen JL, Thiel S. Recombinant mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol 1998;48:116-23.
41. Petersen KA, Matthiesen F, Agger T, et al. Phase 1 safety, tolerability and pharmacokinetic study of recombinant human mannan-binding lectin. J Clin Immunol 2006;26:465-75.
42. Valdimarsson H, Vikingsdottir T, Band P, et al. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 2004;59:97-102.
43. Gomi K, Tokue Y, Kobayashi T, et al. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest 2004;126:95-9.
44. Bonar A, Chmiela M, Rozalska B. Level of mannose-binding lectin (MBL) in patients with tuberculosis [English abstract]. Pneumonol Alergol Pol 2004;72:201-5.
45. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol Immunol 2003;40:73-84.
46. Mok MY, Jack DL, Lau CS, et al. Antibodies to mannose binding lectin in patients with systemic lupus erythematosus. Lupus 2004;13:522-8.
47. Takahashi R, Tsutsumi A, Ohtani K, et al. Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus. Clin Exp Immunol 2004;136:585-90.
48. Gladmann D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
49. Horiuchi T, Gondo H, Miyagawa H, et al. Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT. Genes Immun 2005;6:162-6.
50. Kilpatrick DC, McLintock LA, Allan EK, et al. No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections. Clin Exp Immunol 2003;134:279-84.
51. Bergmann OJ, Christiansen M, Laursen I, et al. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 2003;70:91-7.